Genmab — Februar 2021
-
Er det tegn på at Roche er ved at concede?
-
@JV - jeg regnede med pp. Ellers hænger det ikke sammen
-
Faspro 50% us
sales -
Afhænger af regnskabspraksis
-
Lyder som om man venter ofa godkendelse i denne omgang
-
I EU
-
Timeframe for arbitrage - kan blive i 2021, men kan også gå ind i 2022
-
Gen1046 - expansion cohorts. Der kommer noget omkring combination treatments.
-
Men nævner ikke hvor mange cohorts
-
Mim-8 fase 2 kan komme i løbet af året
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind